Role Of Genetic Factors In Addiction

Impairment of the gene casein kinase1-epsilon (CSNK1E), increases opioid addiction and as well as vulnerability to binge eating, reveals a new study.

Dysfunction of the gene, casein kinase1-epsilon (CSNK1E), increases opioid's euphoric response and produces a marked increase in sensitivity to binge eating in a female experimental model but not in the male.

Prescription Opiods Cause Most ED Visits in 2010
Prescriptions opioids, including methadone, caused 67.8 percent of nationwide emergency department visits in 2010, with the highest proportion opioid overdoses occurring in the South.

‘Addiction is a multi-stage process and the genes linked with risk for opioid addiction could affect one or more of these stages.’

Similar to opioid addiction, very little is known regarding the genetic basis of binge eating. These combined findings provide further support indicating that shared genetic factors may underlie behavioral traits associated with the addictions and eating disorders.

Furthermore, they also provide an important clue that the genetic basis of binge eating and eating disorders in women versus men is likely to differ. The findings appear online in the Journal Genes, Brain and Behavior.

Addiction is a multi-stage process that begins with drug exposure and the initial pleasurable experience and progresses toward tolerance, dependence, physiological and emotional withdrawal upon cessation of use, protracted withdrawal that can last years, and finally, relapse to drug taking.

Long-Term Opioid Use Common Among People With Alzheimer's Disease
Long-term use of transdermal patches was twice as common among persons with Alzheimer's disease.

The genes associated with risk for opioid addiction could potentially affect one or more of these stages.

"Because increasing evidence points toward an association between CSNK1E and opioid addiction in humans, our findings indicate that genetic variation in CSNK1E could function as a potential risk factor that influences the initial pleasurable/euphoric response to opioids and thus, could ultimately have implications for personalized medicine with regard to drug choice for therapeutic treatment (e.g., non-opioid pain relief) and therapeutic dosing of opioids," explained corresponding author Camron Bryant, PhD, assistant professor of pharmacology and experimental therapeutics & psychiatry at BUSM.

Opioid Painkillers Will Have Black Box Warnings in the US
About 40 Americans die every day due to drug overdose and in 2013, over 1.9 million people abused prescription painkillers.

The researchers also believe the female-specific binge eating property associated with Csnk1e dysfunction suggests that different genetic loci (position on the chromosome) are likely to be uncovered for binge eating and eating disorders in women versus men and may lead to sex-specific treatments ultimately being developed for treating eating disorders.

According to the researchers CSNK1E may also play a role in a subset of patients with alcohol use disorders.

New Step Towards Making Painkillers from Genetically Engineered Yeast
Yeast was genetically engineered to convert sugar into hydrocodone, an opioid in the same chemical family as morphine, in just three to five days.

Additionally, CSNK1E is known to be a crucial player in regulating circadian rhythms.

"The potential interaction of CSNK1E with circadian biology in affecting addiction is an unexplored area of investigation that could be a crucial piece to the puzzle in fully understanding its role in the addictions," said Bryant.

Source-Eurekalert